BSE Live
Jan 30, 16:01Prev. Close
4063.00
Open Price
4089.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 30, 15:58Prev. Close
4068.30
Open Price
4065.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
4017.70 (83)
| Cash Flow of Sanofi India (in Rs. Cr.) | Dec 09 | Dec 08 | Dec 07 | Dec 06 | Dec 05 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 241.46 | 259.64 | 222.84 | 249.71 | 236.39 | |
| Net CashFlow From Operating Activities | 137.15 | 119.48 | 103.05 | 127.50 | 153.12 | |
| Net Cash Used In Investing Activities | -30.46 | 204.23 | -11.99 | 7.98 | 14.84 | |
| Net Cash Used From Financing Activities | -43.19 | -43.45 | -84.47 | -42.20 | -42.06 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 2.10 | -1.56 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 63.51 | 280.25 | 4.50 | 93.29 | 125.89 | |
| Cash And Cash Equivalents Begin of Year | 411.37 | 130.28 | 386.12 | 294.39 | 168.50 | |
| Cash And Cash Equivalents End Of Year | 474.88 | 410.53 | 390.62 | 386.12 | 294.39 |
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
01.08.2025
16.07.2025
Emcure Pharma announces deal with Sanofi India to distribute oral anti-diabetic products in India
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
17.03.2025
Sanofi India Consolidated December 2024 Net Sales at Rs 514.90 crore, down 25.8% Y-o-Y
29.07.2024
Sanofi India Consolidated June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y